Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
what is the aim of the host response to viral infection do?
|
prevent entry, but failing this, eliminate the virus as quickly as possible and lessen the amount of damage done by the virus
|
|
what does the host response to viral infection?
|
destroy virus-infected cells, prevent virus replication (w/o killing cells), destroy free virus
|
|
what mechanisms does the host response to viral infection include?
|
innate (nonspecific) & acquired (specific) immunity
|
|
what is innate (nonspecific) immunity?
|
active immediately and against a wide variety of viruses
|
|
what is acquired (specific) immunity?
|
an induced response (requires several days to become active) and active only against the infecting virus
|
|
what are the components of innate (nonspecific) defences?
|
physical barriers, genetic barriers, macrophages, natural killer (NK) cells, interferon, complement, inflammation
|
|
what are the components of acquired (specific) defences?
|
antibody, cytotoxic T cells,
|
|
what is the most powerful weapons in the 'immunological armory'?
|
acquired (specific) defences
|
|
what cells and factors occur when in immune response?
|
INFα first, followed by NK cell (killing), then T cell (killing), followed by antibodies
|
|
how do genetic barriers affect tropism and innate immunity?
|
receptor proteins are genetically determined and the absense of receptor proteins render host resistant to infection
|
|
what is an example of genetic barriers affectings tropism?
|
human beings not susceptible to canine parvovirus (CPV2) due to absense of genes that codae for CPV2 receptors
|
|
what is the primary role of macrophages in host response?
|
phagocytes: engulf and destroy viruses and virus-infected cells
|
|
where are macrophages located?
|
in submucosa through out body, lymph nodes, lung, liver, spleen, blood, body cavities
|
|
what is the task of macrophages?
|
prevent entry, destroy virus infected cells, destroy free virus
|
|
what is the primary role of interferon in host response?
|
cause cells to produce antiviral proteins to prevent virus replication (without killing cells by blocking viral biosynthesis)
|
|
where are IFNs active?
|
produced in response to viral infection (ds RNA, others) and released from infected cell to diffuse to neighboring and distant cells
|
|
what does IFN stand for?
|
interferon
|
|
what does NK stand for ?
|
natural killer
|
|
what are NK cells NOT?
|
non-B, non-T lymphocytes
|
|
what do NK cells do?
|
detect and destroy virus-infected cells
|
|
how are increases in activity of and number of NK cells induced?
|
increased IFN
|
|
how do NK cells recognize virus-infected cells?
|
may detect cells with low levels of MHC class I molecules
|
|
how does the inflammatory response occur during viral infections?
|
virus induced tissue injury results in mast cell degranulation which release vasocactive amines resulting in vasodilation and increased vascular permeability which focuses macrophages, NK cells, complement, IFNs, antibody, cytotoxic T cells at sites of virus infection
|
|
what is the result of an inflammatory response?
|
vasodilation & increased vascular permeability
|
|
what does the complement system do?
|
mediate certain immune responses
|
|
where are complement components found?
|
circulate in blood in inactive forms
|
|
how are complement components activated?
|
contact with antigen-antibody complexes (classical pathway) & contact with the surface of virus or virus-infected cells (alternative pathway)
|
|
what occurs after the activation of complement?
|
form a complex that enzymatically punctures the host cell membrane resulting in cell lysis, releasing by products that cause vasodilation, increase vascular permeability, chemotaxic for neutrophils.
|
|
how is the acquired (specific) immune response generated?
|
by the interaction of macrophages, T cells, and B cells within lymph nodes, spleen, and lymphoid tissues
|
|
what causes B cells to differentiate into antibody producing plasma cells?
|
B cell differentiation via soluble and particulate (viorion) antigens, an exogenous presentation
|
|
what caues T cells to differentiate into cytotoxic T cells?
|
CD+ Tc differentiation driven by virus antigen-MHC1, an endogenous presentation that requires virus infected cells
|
|
how do antibodies participate in the immune response to virus infection?
|
destroy free virus (neutralization), destroy virus-infected cells, & antibody-dependent cell-mediated cyotoxicity (ADCC)
|
|
what is the process of cytotoxic T cell differentiation in acquired immunity?
|
virus infection results in production of viral proteins which are degraded and picked up by MHC1 molecules that are displayed at cell surface where CD8+ cells recognize the virus antigen-MHC I complex (TCR) are directed to differentiate into cytotoxic T cells by TH1 cells, which then attack other virally infected cells displaying the viral antigen-MHC I complex
|
|
what is virus neutralization?
|
antibody destruction of free virus
|
|
how does virus neutralization occur?
|
antibody binds virus and prevents attachment, penetration, uncoating, or antibody binds virus and promotes uptake by macrophages (opsonization), or complement +/- antibody prevents attachment
|
|
how do antibodies detect virus-infected cells?
|
during virus infection, virus proteins are incorporated in cell plasma membrane
|
|
what mechanisms do antibodies use to destroy virus-infected cell?
|
antibody + complement = lysis OR antibody-mediated cell cytotoxicity (ADCC) = lysis
|
|
what does complement consist of?
|
30 serum proteins; numbered C1-C9
|
|
how is the complement activated?
|
by antigen-antibody complexes on by virus-infected cell and surface of virus or virus-infected cell (w/o antibody)
|
|
what is the function of complement?
|
destroy virus infected cells (cell lysis), destroy free virus, inflammation (C3a/C5a)
|
|
how does ADCC work?
|
NK cells, macrophages, PMN recognize infected cell via Fc receptors on antibodies
|
|
what does ADCC stand for?
|
Antibody-dependent cell-mediated cytotoxicity
|
|
what do cytotoxic T cells do?
|
they are virus-specific and recognize infected cells via MHC1-virus progein complex to destroy virus-infected cells via secretion of cytotoxins
|
|
how does recovery occur?
|
if a failure to prevent entry (via physical and genetic barriers, macrophages) activates a wide array of immune responses (interferon, complement, macrophages, NK cells, inflammatory reactions, antibody, cytotoxic T cells)
|
|
how does protection from reinfection occur?
|
protective immunity derived by virus exposure/immunization: antiviral IgA on body surfaces, antiviral IgG in blood, and if antibody is not sufficient, anamnestic T & B cell responses (memory cells) are activated
|
|
what is protective immunity?
|
protection from reinfection
|
|
what is mucosal immunity?
|
immunity to reinfection at a mucosal surface is mediated by: IgA anibodies that are produced by plasma cells in submucosa, circulating antigen-specific T cells, to lesser extent IgG/IgM antibodies
|
|
what is passive immunity?
|
maternally-derived immunity
|
|
what animals require passive immunity?
|
non-primate species which are immunologically naïve at birth and are born into a world teeming with potentially lethal microorganisms
|
|
how is passive immunity acquired?
|
maternal antibodies passed to neonate at birth and during post-partum period via milk and colostrum
|
|
how does passive immunity occur?
|
IgG antibodies are absorbed from intestines to blood during first 1-2 days postpartum, and IgG & IgA in colostrum and milk provide intestinal protection
|
|
how long does passive immunity serum IgG antibodies persist?
|
6 mo (cattle, horses), 3 mo (dogs, cats, pigs), 1 mo (chickens, turkeys)
|
|
what is the primary risk with passive immunity?
|
failure of passive transfer renders neonate susceptible, provides protection for limited time only, interferes with vaccination during the neonatal period
|
|
what can interfere with immunization of neonates?
|
maternal antibodies
|